PF-5006739
| CAS No. | 1293395-67-1 | Cat. No. | BCP29752 |
| Name | PF-5006739 | ||
| Synonyms | PF 5006739; PF5006739; | ||
| Formula | C22H22FN7O | M. Wt | 419.45 |
| Description | PF-5006739 is a Potent CK1δ/ε inhibitor. PF-5006739 attenuates opioid drug-seeking behavior. PF-5006739 possesses a desirable profile, with low nanomolar in vitro potency for CK1δ/ε (IC50 = 3.9 and 17.0 nM, respectively) and high kinome selectivity. In vivo, PF-5006739 demonstrated robust centrally mediated circadian rhythm phase-delaying effects in both nocturnal and diurnal animal models. Further, PF-5006739 dose-dependently attenuated opioid drug-seeking behavior in a rodent operant reinstatement model in animals trained to self-administer fentanyl. | ||
| Pathways | Cell Cycle/DNA Damage Wnt/Stem Cell | ||
| Targets | Casein Kinase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.